Skip to main content
. 2022 Mar 16;12(3):720. doi: 10.3390/diagnostics12030720

Figure 3.

Figure 3

Local FLCκ and IgG concentration of patient samples distributed after ingestion of DMT (median, first, and third quartile). FLCκ—free light chains kappa, DMT—disease-modifying therapy, INF—interferon, GLAT—glatiramer acetate.